Aligned Genetics

238120 · KOSDAQ · ₩238120 · 얼라인드

₩2,440▲ ₩5 (0.21%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

Valuation model · Discounted cash flow (DCF)

We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.

Fair value per share

₩3,268

vs the current price (₩2,440)

Enterprise value
₩40B
Equity value
₩46B
WACC
7.3%

Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.

Bear / Base / Bull

Bear
₩2,318
−5.0%
Base
₩3,268
+34.0%
Bull
₩4,859
+99.1%

Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.

Assumptions

Sign in to change the assumptions and see the results update. Sign in

Cycle options

Margin path

Every year uses the cycle-average margin (18.1%).

Revenue growth

  • 5.2%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (5.2% a year, annual reports), fading to 3% by year 5.

  • 4.7%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (5.2% a year, annual reports), fading to 3% by year 5.

  • 4.1%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (5.2% a year, annual reports), fading to 3% by year 5.

  • 3.6%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (5.2% a year, annual reports), fading to 3% by year 5.

  • 3%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (5.2% a year, annual reports), fading to 3% by year 5.

Business

  • 18.1%

    Operating profit as a share of revenue.

    Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.

  • 27.5%

    Share of operating profit paid as corporate tax.

    Default: Korea's top corporate tax rate (25%) plus 10% local income tax.

  • 3.7%

    The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).

    Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).

  • 4.2%

    Money spent on factories, equipment, software and other long-term assets (% of revenue).

    Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).

  • 40%

    Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.

    Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.

Discount rate

  • 2%

    How fast cash flows keep growing every year after year 5.

    Default: about Korea's long-run inflation plus real growth.

  • 4.11%

    Yield on Korea's 10-year government bond: the return with almost no risk.

    Default: Korea Treasury Bond 10-year yield on 2026-10-28.

  • 0.6

    How much the share moves when the market moves: 1 means just like the market.

    Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.28, adjusted toward 1 and kept between 0.6 and 2.0.

  • 5.5%

    The extra return investors want for owning shares instead of bonds.

    Default: a typical premium for Korean shares.

  • 5.61%

    The interest rate the company would pay to borrow.

    Default: the 10-year yield plus a 1.5% credit spread.

Starting point

Revenue (TTM to H1 2026)
₩16B
Net debt (borrowings and leases − cash and deposits)
₩1B
+ Stakes and investments
₩7.4B
Associates, long-term financial assets and deposits (book value)
Shares
14,218,274
Share price
₩2,440
Market cap
₩35B

TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.

Past years and projection

Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.

FY2023FY2024FY2025Year 1Year 2Year 3Year 4Year 5
Revenue₩15B₩16B₩16B₩17B₩18B₩19B₩19B₩20B
Growth10.6%3.7%1.5%5.2%4.7%4.1%3.6%3.0%
EBIT₩3.3B₩2.8B₩2.4B₩3.1B₩3.2B₩3.4B₩3.5B₩3.6B
EBIT margin21.9%17.6%15.3%18.1%18.1%18.1%18.1%18.1%
After-tax EBIT₩2.4B₩2B₩1.8B₩2.2B₩2.3B₩2.4B₩2.5B₩2.6B
+ Depreciation₩596M₩548M—₩629M₩659M₩686M₩710M₩732M
− Capital spending₩880M₩403M—₩714M₩748M₩778M₩806M₩831M
− Working capital−₩2.2B₩8.2B−₩9.8B₩336M₩320M₩292M₩267M₩230M
Free cash flow₩4.3B−₩6B—₩1.8B₩1.9B₩2B₩2.2B₩2.3B
Discount factor———0.9320.8680.8090.7540.703
Present value———₩1.7B₩1.7B₩1.7B₩1.6B₩1.6B

Terminal value ₩45B, worth ₩32B today: 79% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.

Cross-check: what the market has paid before

For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:

LowTypicalHigh
Price / book (book value ₩2,757 a share)Now 0.88×₩3,5011.27×₩4,9291.79×₩6,4402.34×
Price / earnings (last 12 months: ₩326 a share)Now 7.47×₩3,39910.4×₩4,84314.8×₩9,09227.8×
P/E on run-rate earnings (Q2 2026 × 4: ₩492 a share)Now 4.96×₩5,12510.4×₩7,30114.8×₩13,70727.8×

Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.

Sensitivity

Fair value per share as two inputs change; the middle is the current case.

WACC ↓ · Terminal growth →1.0%1.5%2.0%2.5%3.0%
6.3%₩3,447₩3,667₩3,937₩4,277₩4,720
6.8%₩3,181₩3,356₩3,568₩3,828₩4,156
7.3%₩2,957₩3,100₩3,268₩3,472₩3,722
7.8%₩2,767₩2,884₩3,021₩3,183₩3,379
8.3%₩2,602₩2,699₩2,812₩2,944₩3,100

Now (TTM)

Market cap
₩35B
Enterprise value
₩35B
P/E
7.5×
P/B
0.9×
P/S
2.1×
EV/EBITDA
—
Dividend yield
0.0%

Over time (at each year end)

20252024202320222021
Price₩3,870₩3,025₩4,030₩3,765₩4,285
Market cap₩55B₩43B₩57B₩54B₩61B
P/E18.9×10.4×17.7×22.9×11.0×
P/B1.5×1.2×1.8×1.9×2.3×
P/S3.4×2.7×3.8×3.9×5.2×
EV/EBITDA—10.6×11.8×13.5×22.6×
Dividend yield0.0%————

Versus similar companies

CompanyP/EP/BP/SEV/EBITDADividend yield
Aligned Genetics7.5×0.9×2.1×—0.0%
TSE29.1×6.4×5.4×—0.2%
Kctech21.7×3.3×4.0×16.7×0.5%
Classys12.8×3.2×4.8×10.0×3.7%
Park Systems69.3×4.7×8.3×—0.2%
DI42.0×5.8×2.6×—0.6%
LivsMed—6.7×21.5×—0.0%
Similar companies (median)29.1×5.3×5.1×13.4×0.3%

Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.

Also known as: Aligned Genetics / 얼라인드 / 238120 / KRX:238120

Source: KRX statistical information